U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07236411) titled 'Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants' on Nov. 13.
Brief Summary: The purpose of this study is to determine the absolute bioavailability of SC administered cizutamig in healthy adult participants.
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Healthy Participants Study
Intervention:
BIOLOGICAL: cizutamig
cizutamig will be dosed SC or IV according to the assigned cohort
OTHER: Placebo
placebo will be dosed IV or SC according to the assigned cohort
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Candid Therapeutics
Published by HT Digital Content Services with permissio...